We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breaking the Barrier Toward Nanometer X-ray Resolution

By Biotechdaily staff writers
Posted on 15 Oct 2007
A team of U.S. More...
researchers overcame a major obstacle for using refractive lenses to focus X-rays. This new technique will allow the effective focusing of X-rays down to extremely small spots, and is a significant breakthrough in the development of a new, world-leading light source facility that has potential for new applications in nanoscience, energy, biology, and materials research.

At U.S. Department of Energy's (DOE) Brookhaven National Laboratory's National Synchrotron Light Source (NSLS; Upton, NY,USA), the scientists exceeded a limit on the ability to focus "hard,” or high-energy, X-rays known as the "critical angle.”

The critical angle is the maximum angle that light can be deflected, or bent, by a single surface. For perspective, one should envisage a beam of laser light traveling toward a glass lens. Depending on the characteristics of the lens material and the angle at which the beam is pointed, the light can be refracted, that is, transmitted through the lens but deflected. However, when this light approaches the lens at angles less than the critical angle, the beam does not pass through the lens but is instead reflected. This results in a maximum deflection angle for light that passes through the lens.

"One measure of the quality of an X-ray optic is how small a focused spot it can make,” said NSLS researcher Dr. Ken Evans-Lutterodt. "The problem is that nature does not allow a single lens to deflect the X-rays very much. This limits how small of a spot you can create, and this translates to some fuzziness in the image. To get a sharper image, you need a lens that's more able to deflect the X-rays.”

In 2003, three Brookhaven researchers--Drs. Evans-Lutterodt, Aaron Stein, and James Ablett--were the first to notice the critical angle limit while evaluating the properties of a so-called kinoform lens for focusing hard X-rays. The research team proposed a solution to the critical angle problem of a compound kinoform lens, and both the problem and proposed solution were also suggested later by other researchers in the field.

In the current study, the researchers implemented their theory by creating a compound lens from a series of four kinoform lenses placed one after the other. Using this setup at NSLS beamline X13B, they demonstrated that the critical angle can be exceeded with hard X-rays, while still focusing like a single lens.

This is an important step for the National Synchrotron Light Source II (NSLS-II), a state-of-the-art synchrotron facility that will produce X-rays up to 10,000 times brighter than those generated by the current NSLS and could lead to advances such as alternative-energy technologies and new drugs for fighting disease. One of the key goals of the facility is to probe materials and molecules with just 1-nm resolution--a capability needed to study the intricate mechanisms of chemical and biological systems.

Next, the researchers will measure the resolution their new lens system produces, and will continue to fabricate and test optics that push further beyond the critical angle, and closer to the 1-nm benchmark.

The study's findings were described online in the September 28, 2007, issue of the journal Physical Review Letters.


Related Links:
Brookhaven Laboratory's National Synchrotron Light Source

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.